How synthetic DNA could be used as a sensor

Konstantinos Vavitsas, The University of Queensland

Researchers believe that DNA – the molecule that stores information about life – could one day be used as a type of sensor, to record information based on its surroundings.

Synthetic DNA (not produced in an organism and not containing genetic information of a species) has already been used to store data, as a sort of biological hard drive.

But now, MIT researchers Weixin Tang and David Liu say that their CAMERA system (acronym for CRISPR-mediated analogue multi-event recording apparatus) makes bacteria able to record their surroundings.

The microbes are able to sense and note in their DNA the presence or absence of sunlight, antibiotics, or nutrients in their vicinity.

This system has two variations.

CAMERA 1 records the presence and intensity of an external molecule by changing the ratio of two small circular DNA pieces (called plasmid) inside the bacteria. This allows you to determine whether, how much and for how long the microbe was sensing the external molecule.

CAMERA 2 is more advanced and records by making a DNA edit (imagine the equivalent of burning a DVD, but on the genome).

Both systems can keep the information records steady for several hours. And as a true recording device, it has a “reset” function that cleans the information and sets the system ready for another recording.

How it works

An audio or video recorder in effect translates information. The composition and complexity of photons and sound waves is transformed in a way possible to store. A reading device then retrieves that information.

The same principles apply to recording in DNA format, and in this case there are two technologies that make this possible.

The first one is CRISPR/Cas9, a gene editing tool. CRISPR can target DNA sequences very precisely. In CAMERA 1, CRISPR works by breaking down one of these two circular DNA pieces, changing their ratio.

CAMERA 2 uses CRISPR to make small changes to the original DNA sequence. When the molecule of interest is in the environment, it causes the cells to produce CRISPR in a controlled manner. In that way, the result is precise and tied closely to the external cue.

The second technology is DNA sequencing, and in particular next generation sequencing. The information recorded needs to be retrieved and analysed.

That may sound straightforward, but keep in mind that we need to detect a few changes in a one or two letters out of the few million letters that make the bacterial genome.

Next generation sequencing allows reading DNA in very high speed and very high accuracy. More importantly, it makes the cost of reading DNA drop, making routine sequencing applications financially viable.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    WideCells Group PLC

    More articles like this

    WideCells Group PLC

    Wonder stem cell cure for heart failure

    MILLIONS of heart failure patients could be saved thanks to a new stem cell therapy being tested in Britain. Researchers yesterday revealed a breakthrough treatment that cuts out the need for operations by revitalising damaged tissue

    WideCells Group PLC

    Cord Blood Stem Cells

    Umbilical cord blood stem cells are currently being used to treat more than 80 diseases and disorders, such as leukaemias and aneamias. What are cord blood stem cells? Stem cells found in cord blood are haemopoietic (blood forming). Haemopoietic stem

    WideCells Group PLC

    Why Widecells?

    What’s more important than your health and that of your family? At WideCells we are leading a transformation in stem cell services and stem cell treatment to give you new and better healthcare options. It’s our

    WideCells Group PLC

    What are stems cells?

    It’s estimated that 1 in 3 of us will need a stem cell transplant in our lifetime. What are stem cells? Stem cells are essential for the normal health and functioning of the body, during both development

    WideCells Group PLC

    YOUR BABYCELLS JOURNEY

    Congratulations! No doubt you’re glowing in your pregnancy. With advice and tips coming from all directions, naturally,  as part of your journey you will be wondering how best to protect your family’s future. Your thoughts With

    WideCells Group PLC

    WideCells Group PLC Get Conviction Buy Stance from Align Research

    WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, has today announced that following the Group’s recent placing, Align Research has released an update note

    WideCells Group PLC

    INTERVIEW: Widecells Group Placing and Looking ahead

    Widecells Group Plc (LON:WDC) CEO João Andrade & CFO David Bridgland talk to DirectorsTalk about the lifting of a trading suspension. João explains why the shares were suspended, if anything was hindered as a result and

    WideCells Group PLC

    Wonder stem cell cure for heart failure

    Millions of heart failure patients could be saved thanks to a new stem cell therapy being tested in Britain. Researchers revealed a breakthrough treatment that cuts out the need for operations by revitalising damaged tissue using

    WideCells Group PLC

    WideCells Group PLC Placing Update and Financial Position

    WideCells Group PLC (LON:WDC) the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, provides the following update on its financial position. As announced on 5 June 2018, the

    WideCells Group PLC

    WideCells Group PLC Audited Preliminary Results

    WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, announced today its audited preliminary results for the period ended 31 December 2017. Copies of the

    WideCells Group PLC

    Why do we have blood types?

    More than a century after their discovery, we still don’t really know what blood types are for. Do they really matter? Carl Zimmer investigates. When my parents informed me that my blood type was A+, I

    WideCells Group PLC

    The dangers of unregulated stem cell “therapies”

    Professor Peter Hollands, WideCell’s Group Chief Scientific Officer, comments on unethical and unproven stem cell “therapies” and advises on how to sort the snake oil promises from the genuine science: The early 21st century offers some